OSLO: Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announced the appointment of Dr. Anders Neijber to the position of Chief Medical Officer, Global Medical Affairs and Clinical Development and R&D, effective September 1, 2022. Dr. Neijber is Photocure’s current VP Medical Affairs and Clinical Development and joined the company in August 2021. He…